Results 1 to 10 of about 12,633 (117)
Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case–control dataset [PDF]
Frontiers in NeurologyBackgroundA significant proportion of patients presenting with post-acute sequelae of COVID-19 (PASC) have been found to meet diagnostic criteria for certain disorders of the autonomic nervous system. Substantial gaps remain in our understanding of these
Benjamin C. Pierson +19 more
doaj +2 more sources
An Overview of Vascular Compression Syndromes and Associations with Autonomic Dysfunction: A Review [PDF]
BiomedicinesBackground: Vascular compression syndromes are increasingly recognized as underdiagnosed contributors to morbidity in patients exhibiting dysautonomia.
Brandon M. Davis +6 more
doaj +2 more sources
Revista de Investigación Clínica, 2021 Background: Cerebral hypoperfusion before syncope has been shown in patients with chronic orthostatic intolerance (OI) without tachycardia, but it is unknown if an initial decrease of cerebral blood flow velocity (CBFv) could be related to the vasovagal ...
J. Antonio González-Hermosillo +5 more
doaj +1 more source
Brain Sciences, 2021 The aim of this study was to describe the clinical evolution during 6 months of follow-up of adults recovered from COVID-19. We tried to determine how many met the definition of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
J Antonio González-Hermosillo +6 more
doaj +1 more source
Cutaneous manifestations of orthostatic intolerance syndromes
International Journal of Women's Dermatology, 2021 Dysautonomia refers to a group of autonomic nervous system disorders that affect nearly 70 million people worldwide. One subset of dysautonomia includes syndromes of orthostatic intolerance (OI), which primarily affect adolescents and women of ...
Caroline T. Starling, BSA +4 more
doaj +1 more source
Post-acute sequelae of SARS-CoV-2 syndrome presenting as postural orthostatic tachycardia syndrome [PDF]
Clinical and Experimental Emergency Medicine, 2023 The novel SARS-CoV-2 emerged in 2019, and the global COVID-19 pandemic continues into 2022. It has been known that a subset of patients develops chronic, debilitating symptoms after otherwise complete recovery from acute infection of COVID-19.
Sarah Diekman, Tae Chung
doaj +1 more source
Acquired postganglionic cholinergic dysautonomia – A rare clinical entity
Indian Journal of Ophthalmology. Case Reports, 2021 Acute dysautonomia or dysfunction of the autonomic nervous system is characterized by severe postganglionic sympathetic and parasympathetic dysfunction, with a relative or complete sparing of motor and sensory function. Acquired cholinergic dysautonomia,
Meena Chembil Kakkitampara +2 more
doaj +1 more source
A case of dysautonomia after COVID‐19 infection in a patient with poorly controlled type I diabetes
Clinical Case Reports, 2023 COVID‐19 has been linked to dysautonomia in the current literature, as has uncontrolled diabetes. Here, we present a case report of severe dysautonomia following a COVID‐19 infection in a patient with pre‐existing poorly controlled type‐1 diabetes.
Lorry Aitkens, George Downey
doaj +1 more source
BioMed, 2023 Dysautonomia in the post-COVID-19 condition appears to affect a significant number of patients, with reports raising the incidence up to 61%, having an overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
Dimitrios Spaggoulakis +9 more
doaj +1 more source
The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis
Frontiers in Neurology, 2017 BackgroundMultiple system atrophy (MSA) is a rare, adult-onset, rapidly progressive fatal synucleinopathy that primarily affects oligodendroglial cells in the brain.
Carlos E. Mendoza-Santiesteban +4 more
doaj +1 more source